These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11328978)

  • 21. Patenting biotech beyond the central dogma.
    Wu G
    Nat Biotechnol; 2010 Mar; 28(3):230-3. PubMed ID: 20212482
    [No Abstract]   [Full Text] [Related]  

  • 22. The new section 103(b) of the patent law: an obvious solution?
    Van Horn CE; Barlow SA
    Nat Biotechnol; 1996 Jun; 14(6):773-4. PubMed ID: 9630989
    [No Abstract]   [Full Text] [Related]  

  • 23. Reexamining the research exemption.
    Flores MA; Campbell C
    Nat Biotechnol; 2005 Jun; 23(6):659-61. PubMed ID: 15940230
    [No Abstract]   [Full Text] [Related]  

  • 24. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dr. Moreau has left the island: dealing with human-animal patents in the 21st century.
    Jagels M
    Thomas Jefferson Law Rev; 2000; 23(1):115-47. PubMed ID: 15080119
    [No Abstract]   [Full Text] [Related]  

  • 27. The importance of getting inventorship right.
    Sheiness D; Canady K
    Nat Biotechnol; 2006 Feb; 24(2):153-4. PubMed ID: 16465154
    [No Abstract]   [Full Text] [Related]  

  • 28. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opinions evolve on Kauffman patent.
    Dove A
    Nat Biotechnol; 2000 Apr; 18(4):373. PubMed ID: 10748506
    [No Abstract]   [Full Text] [Related]  

  • 30. Cabilly patent finale.
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):846. PubMed ID: 18688222
    [No Abstract]   [Full Text] [Related]  

  • 31. Super-enzyme patents get their day in court.
    Cyranoski D
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397315
    [No Abstract]   [Full Text] [Related]  

  • 32. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 33. Written description.
    Becker DM
    Nat Rev Drug Discov; 2004 Oct; 3(10):821. PubMed ID: 15497245
    [No Abstract]   [Full Text] [Related]  

  • 34. Of mice and men: patenting the oncomouse.
    Knowles LP
    Hastings Cent Rep; 2003; 33(2):6-7. PubMed ID: 12760110
    [No Abstract]   [Full Text] [Related]  

  • 35. Robert Stoll. Interview by Charlotte Harrison.
    Stoll R
    Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
    [No Abstract]   [Full Text] [Related]  

  • 36. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 37. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 38. Collaborative research presents special problems for patent seekers.
    Thorne LW; Ergenzinger ER; Spruill WM
    Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550
    [No Abstract]   [Full Text] [Related]  

  • 39. Is the viability of the Lilly doctrine on the decline?
    Walker BW; Carty SM
    Nat Biotechnol; 2003 Aug; 21(8):943-4. PubMed ID: 12894207
    [No Abstract]   [Full Text] [Related]  

  • 40. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.